News

Epidarex Capital, EMBL Ventures and Gimv participated together with Evotec in the EUR 14 m ($ 15.75 m) Series A round of Topas Therapeutics GmbH. Evotec will remain

Insights gained will guide the development of potentially improved vaccines against diseases such as influenza, dengue, HIV and other infectious illnesses as well as cancer. "Over the last

Taltz, which is administered as an injection, is indicated for patients who are candidates for systemic therapy or phototherapy. It is a humanized IgG4 monoclonal antibody that selectively

Enstilar is an alcohol-free foam formulation for the topical treatment for psoriasis vulgaris. LEO Pharma president and CEO Gitte Aabo said: "The scientific approval of Enstilar is exciting

The novel compounds, developed in the laboratory of Harvard scientist Matthew Shair, Ph.D., offer an innovative approach to cancer treatment, targeting enzymes that regulate transcription. Acute myeloid leukemia

ANTHIM is indicated in adult and pediatric patients for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of

Ambrx ARX788 may hold the potential for a broader patient population than the currently available Her2 targeting therapies. The multicenter study will be conducted at several sites within

The move is part of a new initiative to counter the disease. Researchers expect to deliver results in 18 months, working with a smallpox virus derivative that may

The drug, however, did not show enough benefit in related inattention and mood complications. Pegvaliase is being tested against a placebo in patients of Phenylketonuria (PKU) or phenylalanine